microdosing tirzepatide twice a week Alternative dosing regimens of GLP‐1 receptor agonists may reduce costs and maintain weight loss efficacy Microdosing GLP-1's for Weight Loss

These distinctions are not merely administrative

A discontinuous drug release profile with a low initial burst and two peaks of drug release at the 2nd and 7th week is observed, corresponding to different mechanisms of exenatide release from microspheres (Figure 5A and B) [79]

The prevalence of MetALD from cohort studies is estimated at 2.2%-2.6% in the general population [3,4] and 31.8%-33.2% of individuals with SLD [5,6]

Side-by-Side Comparison How the Mechanisms Differ in Practice AOD-9604 targets the fat cell itself

Dolan L, Willemsen KV, Linstead PPS, Roberts K, Scheres B (1993) Cellular organisation of the Arabidopsis thaliana root